课题基金 / 基金详情

ADULT AIDS CLINICAL TRIALS UNIT

ADULT AIDS CLINICAL TRIALS UNIT
成人艾滋病临床试验单位
批准号:
2856016
负责人:
Jorge Santana
金额:
$101.42万
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-01-01 至 1999-12-31

项目摘要

项目成果

Jorge Santana的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Hispanic, blacks and women have been disproportionately affected by the AIDS epidemic. Despite increased burden of AIDS cases in these minority populations, access to clinical trials remain low. Puerto Rico (P.R.) ranks second, within all states and territories, in AIDS cases per 100,000 (51.4). AIDS is the leading cause of death for the 20-40 age range group. During the past 5 years, highly significant increments in heterosexual transmission and infection in women have been demonstrated. During the past 3 years we have identified and developed all the necessary infrastructure components for the establishment of an ACTU at the U.P.R., School Medicine. This effort has matured into a research unit with excellent facilities, key research staff, ancillary services and community participation. During our last 6 months we were allowed to enroll patients in ACTG 175. In a 3 month period we evaluated 65 candidates and accrued 16 from all risks behavior groups. As of Dec., 1992, a total of 112 follow-up visits had been recorded with only one missed appointment (visit completion rate of 99%). Only 1 patient was discontinued because of poor compliance and two patients were able to maintain their participation in the protocol by successfully transferring them to ACTU's in USA. It is then, imperative, that an adult ACTU in P.R. be available as a research tool and as a much needed therapeutic alternative.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ANTIRETROVIRAL EFFECT OF IMMUNIZATION WITH THE MRK AD5 HIV-1 GAG VACCINE
A5178: "PEG-IFN PLUS RBV FOR HCV CO-INFECTION"
TDM ON VIRAL LOAD RESPONSE TO PROTEASE INHIBITOR CONTAINING SALVAGE THERAPY
A5223-SEX DIFFERENCES IN LOPINAVIR/RITONAVIR PHARMACOKINETICS
海外基金